RedHill Biopharma Announces First Half 2024 Business Highlights

A transformed RedHill:

R&D and Commercial Highlights:

Financial highlights:

TEL AVIV, Israel and RALEIGH, N.C., Aug. 29, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its first half 2024 financial results and operational highlights, for the six months ended June 30, 2024.

Read more at prnewswire.com